A new bill in Indiana would create a psilocybin research fund aimed at providing money to research institutions studying the psychedelic as an alternative treatment for mental health and medical disorders, from PTSD to migraines.
The proposal, SB 139, was introduced this week by Sen. Ed Charbonneau (R) and already has a hearing scheduled before the Senate Health and Provider Services Committee on Wednesday.
If passed, the measure would not amend Indiana’s criminal laws around psilocybin but would instead help pay for clinical trials into the drug’s efficacy, especially among military veterans and first responders.
The legislation would create a therapeutic psilocybin research fund “for the purpose of providing financial assistance to research institutions in Indiana to study…the use of psilocybin to treat mental health and other medical conditions.”
Researchers would need to apply to the state Department of Health to receive funds to study the substance as a treatment for conditions, six of which are specified in the bill: PTSD “with a focus on treating the disorder in combat veterans and first responders,” anxiety, depression, bipolar disorder, chronic pain and migraines.
The studies would need to “compare the efficacy of psilocybin as a treatment for mental health and other
Read full article on Marijuana Moment
